progenitor-cells

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy approved for a Phase I clinical trial. It's a historical milestone that could reverse what has, until now, been an incurable injury.

A newly discovered cell that matures into two specialist cell types significantly boosts wound healing, according to new research. It could be a game-changer for people suffering from chronic, hard-to-heal wounds.